Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness

Purpose. To report on an improved botulinum toxin injection with conjunctival microincision for beginners, and to determine the effectiveness of botulinum toxin A (BTXA) in the treatment of patients with acute acquired comitant esotropia (AACE). Methods. Medical records of 29 AACE patients were retr...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjia Xu, Weifeng Sun, Shuying Dai, Yanyan Cheng, Jing Zhao, Yuan Liu, Juan Wang, Ya’nan Wang, Yu Gao, Huifang Han, Aijun Han
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2020/1702695
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551714053423104
author Hongjia Xu
Weifeng Sun
Shuying Dai
Yanyan Cheng
Jing Zhao
Yuan Liu
Juan Wang
Ya’nan Wang
Yu Gao
Huifang Han
Aijun Han
author_facet Hongjia Xu
Weifeng Sun
Shuying Dai
Yanyan Cheng
Jing Zhao
Yuan Liu
Juan Wang
Ya’nan Wang
Yu Gao
Huifang Han
Aijun Han
author_sort Hongjia Xu
collection DOAJ
description Purpose. To report on an improved botulinum toxin injection with conjunctival microincision for beginners, and to determine the effectiveness of botulinum toxin A (BTXA) in the treatment of patients with acute acquired comitant esotropia (AACE). Methods. Medical records of 29 AACE patients were retrospectively analyzed. BTXA was injected into the unilateral or bilateral medial rectus muscle with conjunctival microincision without electromyographic guidance. Success was defined as total horizontal deviation ≤10 prism diopters (PD) and evidence of binocular vision. Results. Twenty-nine patients were included, of whom 22 were male and 7 were female. The mean age at onset was 14.2 ± 7.4 (range, 4–34) years. The mean time from onset of AACE to injection was 18.4 ± 20.3 (range, 1–96) weeks. All patients completed at least 6 months of follow-up, and the mean follow-up after BTXA injection was 12.3 ± 4.8 months (range, 7–24 months). Neurological evaluation and brain magnetic resonance imaging (MRI) were unremarkable in all patients. The mean spherical equivalent refraction was −1.22 ± 2.85D and −0.97 ± 2.80D in the right and left eyes, respectively. Mean preinjective esotropia was 38.4 ± 18.9 PD (range, +10–+80 PD) at near and 40.2 ± 17.7 PD (range, +20–+80 PD) at far distance. The mean angle of deviation at 6 months after injection was 0.6 ± 4.1 PD (range, −3–+15 PD) at near and 3.0 ± 5.9 PD (range, 0–+20 PD) at far distance. There was significant difference in the angle of deviation at near and far fixation between pre-BTXA and post-BTXA 6 months (p<0.001, p<0.001, resp.). There was no significant difference in the angle of deviation at near and far fixation between post-BTXA 6 months and post-BTXA at final follow-up (p = 0.259 and 0.326, resp.). Mean stereoacuity improved from 338 to 88 arc seconds. During the follow-up period, 5 of 29 patients had recurrent esotropia. Two patients refused all further treatment, and the other 3 patients required incisional strabismus surgery. The success rates were 86.2% (25/29) at 6 months and 82.8% (24/29) at final follow-up. Conclusion. Conjunctival microincision injection of botulinum toxin is a practical and safe method for beginners to locate an extraocular muscle, which is as effective as the traditional methods. Botulinum toxin injection can be preferred as the first-line treatment for AACE patients with potential binocular vision.
format Article
id doaj-art-fd5e8577072e4500b4d0e4538703a195
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-fd5e8577072e4500b4d0e4538703a1952025-02-03T06:00:48ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/17026951702695Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its EffectivenessHongjia Xu0Weifeng Sun1Shuying Dai2Yanyan Cheng3Jing Zhao4Yuan Liu5Juan Wang6Ya’nan Wang7Yu Gao8Huifang Han9Aijun Han10Department of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaDepartment of Ophthalmology, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Eye Hospital, Xingtai, Hebei Province 054000, ChinaPurpose. To report on an improved botulinum toxin injection with conjunctival microincision for beginners, and to determine the effectiveness of botulinum toxin A (BTXA) in the treatment of patients with acute acquired comitant esotropia (AACE). Methods. Medical records of 29 AACE patients were retrospectively analyzed. BTXA was injected into the unilateral or bilateral medial rectus muscle with conjunctival microincision without electromyographic guidance. Success was defined as total horizontal deviation ≤10 prism diopters (PD) and evidence of binocular vision. Results. Twenty-nine patients were included, of whom 22 were male and 7 were female. The mean age at onset was 14.2 ± 7.4 (range, 4–34) years. The mean time from onset of AACE to injection was 18.4 ± 20.3 (range, 1–96) weeks. All patients completed at least 6 months of follow-up, and the mean follow-up after BTXA injection was 12.3 ± 4.8 months (range, 7–24 months). Neurological evaluation and brain magnetic resonance imaging (MRI) were unremarkable in all patients. The mean spherical equivalent refraction was −1.22 ± 2.85D and −0.97 ± 2.80D in the right and left eyes, respectively. Mean preinjective esotropia was 38.4 ± 18.9 PD (range, +10–+80 PD) at near and 40.2 ± 17.7 PD (range, +20–+80 PD) at far distance. The mean angle of deviation at 6 months after injection was 0.6 ± 4.1 PD (range, −3–+15 PD) at near and 3.0 ± 5.9 PD (range, 0–+20 PD) at far distance. There was significant difference in the angle of deviation at near and far fixation between pre-BTXA and post-BTXA 6 months (p<0.001, p<0.001, resp.). There was no significant difference in the angle of deviation at near and far fixation between post-BTXA 6 months and post-BTXA at final follow-up (p = 0.259 and 0.326, resp.). Mean stereoacuity improved from 338 to 88 arc seconds. During the follow-up period, 5 of 29 patients had recurrent esotropia. Two patients refused all further treatment, and the other 3 patients required incisional strabismus surgery. The success rates were 86.2% (25/29) at 6 months and 82.8% (24/29) at final follow-up. Conclusion. Conjunctival microincision injection of botulinum toxin is a practical and safe method for beginners to locate an extraocular muscle, which is as effective as the traditional methods. Botulinum toxin injection can be preferred as the first-line treatment for AACE patients with potential binocular vision.http://dx.doi.org/10.1155/2020/1702695
spellingShingle Hongjia Xu
Weifeng Sun
Shuying Dai
Yanyan Cheng
Jing Zhao
Yuan Liu
Juan Wang
Ya’nan Wang
Yu Gao
Huifang Han
Aijun Han
Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
Journal of Ophthalmology
title Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
title_full Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
title_fullStr Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
title_full_unstemmed Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
title_short Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
title_sort botulinum toxin injection with conjunctival microincision for the treatment of acute acquired comitant esotropia and its effectiveness
url http://dx.doi.org/10.1155/2020/1702695
work_keys_str_mv AT hongjiaxu botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT weifengsun botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT shuyingdai botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT yanyancheng botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT jingzhao botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT yuanliu botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT juanwang botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT yananwang botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT yugao botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT huifanghan botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness
AT aijunhan botulinumtoxininjectionwithconjunctivalmicroincisionforthetreatmentofacuteacquiredcomitantesotropiaanditseffectiveness